ID
15199
Beschrijving
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany
Link
https://clinicaltrials.gov/ct2/show/NCT02419378
Trefwoorden
Versies (4)
- 13.08.15 13.08.15 - Martin Dugas
- 22.05.16 22.05.16 -
- 28.05.16 28.05.16 -
- 31.05.16 31.05.16 -
Geüploaded op
22. Mai 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0 Legacy
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
EDSS Multiple Sclerosis ALAIN01 NCT02419378
EDSS Multiple Sclerosis ALAIN01 NCT02419378
- StudyEvent: SE
Similar models
EDSS Multiple Sclerosis ALAIN01 NCT02419378
- StudyEvent: SE
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0449438 (UMLS CUI [1,3])
C1321512 (UMLS CUI [1,2])
C0006121 (UMLS CUI [1,2])
C0228060 (UMLS CUI [1,2])
C0007765 (UMLS CUI [1,2])
C0682648 (UMLS CUI [1,2])
C0006104 (UMLS CUI [1,2])
C0080331 (UMLS CUI [1,2])
C0007765 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0449438 (UMLS CUI [1,3])
C0947611 (UMLS CUI [1,2])
C1955348 (UMLS CUI [1,2])